163 related articles for article (PubMed ID: 21524245)
1. Vitamin D treatment in primary hyperparathyroidism.
Rolighed L; Bollerslev J; Mosekilde L
Curr Drug Saf; 2011 Apr; 6(2):100-7. PubMed ID: 21524245
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
Grey A; Lucas J; Horne A; Gamble G; Davidson JS; Reid IR
J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D.
Tucci JR
Eur J Endocrinol; 2009 Jul; 161(1):189-93. PubMed ID: 19383807
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy.
Mikhail N
South Med J; 2011 Jan; 104(1):29-33. PubMed ID: 21079532
[TBL] [Abstract][Full Text] [Related]
7. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
Walker MD; Saeed I; Lee JA; Zhang C; Hans D; Lang T; Silverberg SJ
Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperparathyroidism and the skeleton.
Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
[TBL] [Abstract][Full Text] [Related]
10. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
11. [Half of the patients with primary hyperparathyroidisms have a vitamin D deficiency: aggravating the osseous attack].
Velayoudom-Cephise FL; Foucan L; Soudan B; Cardot-Bauters C; Vantyghem MC; D'herbomez M; Tison-Muchery F; Wemeau JL
Presse Med; 2011 Feb; 40(2):e120-7. PubMed ID: 21036004
[TBL] [Abstract][Full Text] [Related]
12. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
Shah VN; Shah CS; Bhadada SK; Rao DS
Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
[TBL] [Abstract][Full Text] [Related]
13. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
Lee JH; Kim JH; Hong AR; Kim SW; Shin CS
Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis.
Song A; Zhao H; Yang Y; Liu S; Nie M; Wang O; Xing X
J Endocrinol Invest; 2021 Aug; 44(8):1667-1677. PubMed ID: 33453021
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin D replacement in primary hyperparathyroidism with concurrent vitamin D deficiency: a systematic review and meta-analysis.
Loh HH; Lim LL; Yee A; Loh HS; Vethakkan SR
Minerva Endocrinol; 2019 Jun; 44(2):221-231. PubMed ID: 28294593
[TBL] [Abstract][Full Text] [Related]
16. Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism.
Weaver S; Doherty DB; Jimenez C; Perrier ND
World J Surg; 2009 Nov; 33(11):2292-302. PubMed ID: 19308641
[TBL] [Abstract][Full Text] [Related]
17. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
18. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
[TBL] [Abstract][Full Text] [Related]
19. Management of hypovitaminosis D in patients with primary hyperparathyroidism.
Rathi MS; Gonzalez S; Wright D; Ellis NR; Peacey SR
J Endocrinol Invest; 2014 May; 37(5):467-71. PubMed ID: 24515299
[TBL] [Abstract][Full Text] [Related]
20. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism.
Bollerslev J; Marcocci C; Sosa M; Nordenström J; Bouillon R; Mosekilde L
Eur J Endocrinol; 2011 Dec; 165(6):851-64. PubMed ID: 21964961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
